FIELD: pharmaceutics.
SUBSTANCE: in the general formula (I) R represents hydrogen, C1-6alkyl, fused bicyclic or arylalkenylaryl.
EFFECT: pharmaceutical composition based on compounds of formula (I); a method of treating hyperlipidaemia and hypercholesterolaemia, as well as a method of increasing serum level of high density lipoprotein (HDL) and a method of reducing low density lipoprotein (LDL) using same.
14 cl, 23 dwg, 8 tbl, 8 ex
